XML 79 R63.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Compensation - Schedule of Contingent Restricted Stock (Details)
12 Months Ended
Jun. 30, 2017
USD ($)
$ / shares
shares
Contingent Restricted Stock Grants  
Number of Restricted Stock Units  
Nonvested, beginning of period (shares) | shares 91,172
Vested (shares) | shares (32,376)
Nonvested, end of period (shares) | shares 113,270
Weighted Average Grant-Date Fair Value  
Weighted average grant date fair value, beginning of period (in USD per share) | $ / shares $ 5.21
Vested, weighted average grant date fair value (in USD per share) | $ / shares 6.09
Weighted average grant date fair value, end of period (in USD per share) | $ / shares $ 4.64
Unamortized compensation expense | $ $ 121,668 [1]
Weighted Average Remaining Amortization Period (in years) 2 years 1 month 6 days
Contingent Restricted Stock, Performance Based  
Number of Restricted Stock Units  
Grants (shares) | shares 27,237
Nonvested, end of period (shares) | shares 39,403
Weighted Average Grant-Date Fair Value  
Grants, weighted average grant date fair value (in USD per share) | $ / shares $ 5.67
Weighted average grant date fair value, end of period (in USD per share) | $ / shares $ 7.02
Potential future compensation expense | $ $ 276,702
Contingent Restricted Stock, Market Based  
Number of Restricted Stock Units  
Grants (shares) | shares 27,237
Nonvested, end of period (shares) | shares 73,867
Weighted Average Grant-Date Fair Value  
Grants, weighted average grant date fair value (in USD per share) | $ / shares $ 3.42
Weighted average grant date fair value, end of period (in USD per share) | $ / shares $ 3.37
[1] Excludes $276,702 of potential future compensation expense for 39,403 shares of performance-based awards for which vesting is not considered probable at this time for accounting purposes.